Emerging World Pharma, Inc.

Emerging World Pharma, Inc.

EWPI
Emerging World Pharma, Inc.US flagOther OTC
0.00
USD
- -
- -
11,930.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Terry Agrivos
Sector
Financial Services
Industry
Financial - Conglomerates
Address
Pastoral Road Sunyani United States of America
IPO Date
Mar 29, 2000
Business
Emerging World Pharma, Inc. (EWPI) invests in generic-based pharmaceutical companies manufacturing within developing nations; provides production infrastructure, hiring and training of local employees, and raw materials to these companies; focuses investments on pharmaceutical firms with contracts to church and other non-governmental organizations, governments, and wholesalers. The company operates primarily in developing regions including Ghana, targeting self-sufficiency in medicine needs for emerging markets. Founded in 1997 and headquartered in Sunyani, Ghana, at Pastoral Road, Block 11A, it trades on OTC Pink Sheets and was formerly known as Tubearoo, Inc., changing its name in November 2009. No major recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts reported within the last 1-2 years; the company remains a developing-stage entity with minimal revenue and ongoing net losses.